143 related articles for article (PubMed ID: 30340078)
1. Clinical utility of susceptibility-weighted MR sequence for the evaluation of uterine sarcomas.
Takeuchi M; Matsuzaki K; Harada M
Clin Imaging; 2019; 53():143-150. PubMed ID: 30340078
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Red Degeneration of Uterine Leiomyoma with Susceptibility-weighted MR Imaging.
Takeuchi M; Matsuzaki K; Bando Y; Harada M
Magn Reson Med Sci; 2019 Apr; 18(2):158-162. PubMed ID: 30270253
[TBL] [Abstract][Full Text] [Related]
3. Investigating the diagnostic value of quantitative parameters based on T2-weighted and contrast-enhanced MRI with psoas muscle and outer myometrium as internal references for differentiating uterine sarcomas from leiomyomas at 3T MRI.
Malek M; Rahmani M; Seyyed Ebrahimi SM; Tabibian E; Alidoosti A; Rahimifar P; Akhavan S; Gandomkar Z
Cancer Imaging; 2019 Apr; 19(1):20. PubMed ID: 30935419
[TBL] [Abstract][Full Text] [Related]
4. Combined use of T2-weighted and diffusion-weighted 3-T MR imaging for differentiating uterine sarcomas from benign leiomyomas.
Namimoto T; Yamashita Y; Awai K; Nakaura T; Yanaga Y; Hirai T; Saito T; Katabuchi H
Eur Radiol; 2009 Nov; 19(11):2756-64. PubMed ID: 19504102
[TBL] [Abstract][Full Text] [Related]
5. Assessment of MR Imaging as a Tool to Differentiate between the Major Histological Types of Uterine Sarcomas.
Sumi A; Terasaki H; Sanada S; Uchida M; Tomioka Y; Kamura T; Yano H; Abe T
Magn Reson Med Sci; 2015; 14(4):295-304. PubMed ID: 26104072
[TBL] [Abstract][Full Text] [Related]
6. Machine Learning to Differentiate T2-Weighted Hyperintense Uterine Leiomyomas from Uterine Sarcomas by Utilizing Multiparametric Magnetic Resonance Quantitative Imaging Features.
Nakagawa M; Nakaura T; Namimoto T; Iyama Y; Kidoh M; Hirata K; Nagayama Y; Yuki H; Oda S; Utsunomiya D; Yamashita Y
Acad Radiol; 2019 Oct; 26(10):1390-1399. PubMed ID: 30661978
[TBL] [Abstract][Full Text] [Related]
7. Uterine sarcoma vs adenocarcinoma: can MRI distinguish between them?
Hernández Mateo P; Méndez Fernández R; Serrano Tamayo E
Radiologia; 2016; 58(3):199-206. PubMed ID: 26617259
[TBL] [Abstract][Full Text] [Related]
8. Preliminary observations and clinical value of lipid peak in high-grade uterine sarcomas using in vivo proton MR spectroscopy.
Takeuchi M; Matsuzaki K; Harada M
Eur Radiol; 2013 Sep; 23(9):2358-63. PubMed ID: 23740024
[TBL] [Abstract][Full Text] [Related]
9. MR imaging of uterine sarcomas.
Sahdev A; Sohaib SA; Jacobs I; Shepherd JH; Oram DH; Reznek RH
AJR Am J Roentgenol; 2001 Dec; 177(6):1307-11. PubMed ID: 11717072
[TBL] [Abstract][Full Text] [Related]
10. MR imaging features of uterine adenomyomas.
Song SE; Sung DJ; Park BJ; Kim MJ; Cho SB; Kim KA
Abdom Imaging; 2011 Aug; 36(4):483-8. PubMed ID: 20652694
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance and diffusion-weighted imaging in categorization of uterine sarcomas: correlation with pathological findings.
Zhang GF; Zhang H; Tian XM; Zhang H
Clin Imaging; 2014; 38(6):836-44. PubMed ID: 25027800
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Algorithm to Differentiate Benign Atypical Leiomyomas from Malignant Uterine Sarcomas with Diffusion-weighted MRI.
Abdel Wahab C; Jannot AS; Bonaffini PA; Bourillon C; Cornou C; Lefrère-Belda MA; Bats AS; Thomassin-Naggara I; Bellucci A; Reinhold C; Fournier LS
Radiology; 2020 Nov; 297(2):361-371. PubMed ID: 32930650
[TBL] [Abstract][Full Text] [Related]
13. Mixed müllerian sarcoma of the uterus: MR imaging findings.
Shapeero LG; Hricak H
AJR Am J Roentgenol; 1989 Aug; 153(2):317-9. PubMed ID: 2546411
[TBL] [Abstract][Full Text] [Related]
14. The value of detection of flow voids between the uterus and the leiomyoma with MRI.
Torashima M; Yamashita Y; Matsuno Y; Takahashi M; Nakahara K; Onitsuka Y; Ohtake H; Tanaka N; Okamura H
J Magn Reson Imaging; 1998; 8(2):427-31. PubMed ID: 9562071
[TBL] [Abstract][Full Text] [Related]
15. The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas.
Tamai K; Koyama T; Saga T; Morisawa N; Fujimoto K; Mikami Y; Togashi K
Eur Radiol; 2008 Apr; 18(4):723-30. PubMed ID: 17929022
[TBL] [Abstract][Full Text] [Related]
16. MR imaging in the evaluation of benign uterine masses: value of gadopentetate dimeglumine-enhanced T1-weighted images.
Hricak H; Finck S; Honda G; Göranson H
AJR Am J Roentgenol; 1992 May; 158(5):1043-50. PubMed ID: 1566664
[TBL] [Abstract][Full Text] [Related]
17. Uterine tumors: comparison of 3D versus 2D T2-weighted turbo spin-echo MR imaging at 3.0 T--initial experience.
Hori M; Kim T; Onishi H; Ueguchi T; Tatsumi M; Nakamoto A; Tsuboyama T; Tomoda K; Tomiyama N
Radiology; 2011 Jan; 258(1):154-63. PubMed ID: 21045182
[TBL] [Abstract][Full Text] [Related]
18. A machine learning approach for distinguishing uterine sarcoma from leiomyomas based on perfusion weighted MRI parameters.
Malek M; Gity M; Alidoosti A; Oghabian Z; Rahimifar P; Seyed Ebrahimi SM; Tabibian E; Oghabian MA
Eur J Radiol; 2019 Jan; 110():203-211. PubMed ID: 30599861
[TBL] [Abstract][Full Text] [Related]
19. Osseous invasion by soft-tissue sarcoma: assessment with MR imaging.
Elias DA; White LM; Simpson DJ; Kandel RA; Tomlinson G; Bell RS; Wunder JS
Radiology; 2003 Oct; 229(1):145-52. PubMed ID: 14519874
[TBL] [Abstract][Full Text] [Related]
20. Parametrial invasion in cervical carcinoma: evaluation of detection at MR imaging with fat suppression.
Scheidler J; Heuck AF; Steinborn M; Kimmig R; Reiser MF
Radiology; 1998 Jan; 206(1):125-9. PubMed ID: 9423661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
